Canadian ALS experts push for equitable access to genetic testing across the country
October 07, 2025
The approval of Qalsody (tofersen) by Health Canada marked a transformative moment in the treatment of ALS caused by pathogenic variants in the SOD1 gene. This new genetic therapy offers hope for a subset of people with ALS and marks…
Continue reading